Cell replacement therapies may help treat Parkinson’s disease


Team Udayavani, Feb 18, 2019, 9:02 AM IST

Washington: Cell replacement therapies may help alleviate the symptoms of Parkinson’s disease, a progressive disorder that currently has no cure, scientists say.

According to a study published in the Journal of Parkinson’s Disease, newly developed stem cell technologies could be used to treat the disease.

The most common Parkinson’s disease treatment today is based on enhancing the activity of the nigro-striatal pathway in the brain with dopamine-modulating therapies, thereby increasing striatal dopamine levels and improving motor impairment associated with the disease.

However, this treatment has significant long-term limitations and side effects. Stem cell technologies show promise for treating Parkinson’s Disease and may play an increasing role in alleviating at least the motor symptoms, if not others, in the decades to come.

“We are in desperate need of a better way of helping people with Parkinson’s disease. It is on the increase worldwide. There is still no cure, and medications only go part way to fully treat incoordination and movement problems,” said Claire Henchcliffe, from Weill Cornell Medical College in the US.

“If successful, using stem cells as a source of transplantable dopamine-producing nerve cells could revolutionize care of the Parkinson’s disease patient in the future,” said Malin Parmar, from Lund University in Sweden.

“A single surgery could potentially provide a transplant that would last throughout a patient’s lifespan, reducing or altogether avoiding the need for dopamine-based medications,” said Parmar.

Researchers have analysed how newly developed stem cell technologies could be used to treat Parkinson’s disease, and how clinical researchers are moving very quickly to translate this technology to early clinical trials.

In the past, most transplantation studies in PD used human cells from aborted embryos. While these transplants could survive and function for many years, there were scientific and ethical issues — foetal cells are in limited supply, and they are highly variable and hard to quality control.

Only some patients benefited, and some developed side effects from the grafts, such as uncontrollable movements called dyskinesias.

Recent strides in stem cell technology mean that quality, consistency, activity, and safety can be assured, and that it is possible to grow essentially unlimited amounts of dopamine-producing nerve cells in the laboratory for transplantation.

This approach is now rapidly moving into initial testing in clinical trials, researchers said.

The choice of starting material has also expanded with the availability of multiple human embryonic stem cell lines, as well as the possibilities for producing induced pluripotent cells, or neuronal cells from a patient’s own blood or skin cells.

The first systematic clinical transplantation trials using pluripotent stem cells as donor tissue were initiated in Japan in 2018.

The first-generation cells are now being trialed and new advances in stem cell biology and genetic engineering promise even better cells and therapies in the future, researchers said.

“With several research groups, including our own centres, quickly moving towards testing of stem cell therapies for Parkinson’s disease, there is not only a drive to improve what is possible for our patients, but also a realisation that our best chance is harmonising efforts across groups,” said Henchcliffe.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Mangaluru: Lecturer succumbs to food allergy; Organs donated

Karnataka sets up panel for internal reservation among STs

Maharashtra Assembly Elections 2024 | Congress in clutches of urban naxals, became puppet of people with divisive agenda: J P Nadda

Even if Indira Gandhi returns from heaven, Article 370 will not be restored: Amit Shah

Tilak Varma slams ton as India take 2-1 lead against South Africa with 11-run win in third T20I

PM Modi to visit Bihar’s Jamui to commemorate Janjatiya Gaurav Divas

BJP offered Rs 50 cr each to 50 Cong MLAs to remove Karnataka govt: CM Siddaramaiah

Related Articles More

Disruption in liver-brain communication behind overeating, Study claims

Acute Blood Shortage at Kasturba Hospital, Manipal: Donate blood and save lives

50-60% cancer cases detected in India annually are preventable, say oncologists

Doctors report treating ‘petticoat cancer’ in women who might have tied sarees tightly at waist

The Role of Screening and Early Detection in Liver Cancer

MUST WATCH

Punganur Cow

Rangoli design

Jagadeesh Nagaraj Kudupali Audio Viral

Gho Pooja in Deepavali Festival

Melukote Deepavali


Latest Additions

Haryana Shiv Sena leader claims he received threat call from Bishnoi gang

Vitla: Tree falls on truck, blocks Mani-Mysuru State Highway

Mangaluru: Lecturer succumbs to food allergy; Organs donated

Byelections: 81.84 per cent voter turnout in bypolls in three Assembly segments in Karnataka

Karnataka sets up panel for internal reservation among STs

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.